Cargando…
Adjunctive Use of Ketamine for Benzodiazepine-Resistant Severe Alcohol Withdrawal: a Retrospective Evaluation
INTRODUCTION: Benzodiazepine (BZD)-resistant alcohol withdrawal remains a challenge for most institutions due to limited evidence with available agents. One published study currently exists utilizing the N-methyl-d-aspartate antagonist, ketamine, for alcohol withdrawal. OBJECTIVE: The purpose of our...
Autores principales: | Shah, Poorvi, McDowell, Marc, Ebisu, Reika, Hanif, Tabassum, Toerne, Theodore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097970/ https://www.ncbi.nlm.nih.gov/pubmed/29748926 http://dx.doi.org/10.1007/s13181-018-0662-8 |
Ejemplares similares
-
Ketamine: A Potential Adjunct for Severe Benzodiazepine Withdrawal
por: Purcell, Kristen, et al.
Publicado: (2021) -
Catatonia in mixed alcohol and benzodiazepine withdrawal
por: Basu, Aniruddha, et al.
Publicado: (2014) -
Dexmedetomidine as adjunct treatment for severe alcohol withdrawal in the ICU
por: Rayner, Samuel G, et al.
Publicado: (2012) -
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
por: Garel, Nicolas, et al.
Publicado: (2023) -
Return Encounters in Emergency Department Patients Treated with Phenobarbital Versus Benzodiazepines for Alcohol Withdrawal
por: Lebin, Jacob A., et al.
Publicado: (2021)